The share of China's scientific publications in the top 10% most-cited works on infectious diseases has shown a positive trajectory. In 2023, the share was 11.31%. Forecasts indicate growth, with percentages rising from 11.62% in 2024 to 13.03% in 2028, reflecting a Compound Annual Growth Rate (CAGR) of 2.58%. This consistent upward trend illustrates China's strengthening presence in the infectious diseases research domain and increasing global influence.

Future trends to watch for:

Increased research funding and collaboration efforts may further boost publication quality and citation impact.
Potential shifts in research focus driven by global health challenges and innovation in medical technology.
Emerging partnerships with international researchers could diversify research outputs and citations.